EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating of Serum Potassium Levels in Patients with Kidney Disease

Dhafar Mohamed Hasan Al-Shareefy

JOURNAL OF UNIVERSITY OF BABYLON for Pure and Applied Sciences · 30.09.2026 · 34 (3) · 505-518

DOI: 10.29196/jubpas.v34i3.6845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JOURNAL OF UNIVERSITY OF BABYLON for Pure and Applied Sciences, online erschienen am 30.09.2026. Verfasst von Dhafar Mohamed Hasan Al-Shareefy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The key role of potassium as a basic electrolyte for proper cardiac, membrane excitability and neuromuscular activity, and cellular homeostasis. Potassium homeostasis is intrinsically dependent on renal control, which is a dominant mechanism and, under poor kidney functioning, potassium homeostasis can be greatly demised. Both hypokalemia and hyperkalemia are clinically important electrolyte disorders compromising cardiovascular and neuromuscular function, which in extreme cases can put patients at risk for serious life-threatening cardiac arrhythmias. Hyperkalemia is particularly relevant in renal disease as poor potassium excretion can lead to accumulation in the extracellular compartment. Conversely, or loss of potassium from the kidney secondary to increased tubular potassium loss, changes in tubular handling, drug therapy or other disturbance of electrolyte balance causing hypokalemia. Hypokalemia was defined as a serum potassium concentration of 5.0 mmol/L. Patients with serum potassium concentrations within the range of 3.5–5.0 mmol/L were considered to have normal serum potassium levels. These definitions were applied consistently to determine the prevalence and patterns of hypokalemia and hyperkalemia among the study participants. Materials and Methods: This study evaluated serum potassium and potassium abnormalities in 100 kidney disease patients. Study Schedule: The study conducted on 21 November 2024 to 16 March 2025 in Marjan Teaching Hospital, Babylon, Iraq. Patients were stratified by age, with trends of hypokalemia and hyperkalemia being determined for various serum potassium concentrations. A total of 100 patients who met the predefined eligibility criteria were included in the study. The sample size was determined based on the number of eligible patients available during the study period and was therefore considered a convenience/consecutive sample rather than a sample calculated using a formal prevalence-based sample size equation Results: The results showed an association of age, sex and type of potassium imbalance and the importance of kidney function in electrolyte regulation. A total of 100 patients were included in the study. Hypokalemia was identified in patients (21%), whereas hyperkalemia was identified in patients (46%)

Conclusion

The aim of this study is to review the importance of regular monitoring of potassium in patients with renal disease to avoid serious complications like arrhythmia and cardiac arrest. Ethical approval and patient consent was obtained prior to sample collection.

Zitieren

APA

Al-Shareefy, D. M. H. (2026). Evaluating of Serum Potassium Levels in Patients with Kidney Disease. JOURNAL OF UNIVERSITY OF BABYLON for Pure and Applied Sciences, 34(3), 505-518. https://doi.org/10.29196/jubpas.v34i3.6845

Vancouver

Al-Shareefy DMH. Evaluating of Serum Potassium Levels in Patients with Kidney Disease. JOURNAL OF UNIVERSITY OF BABYLON for Pure and Applied Sciences. 2026;34(3):505-518. doi:10.29196/jubpas.v34i3.6845

BibTeX
@article{AlShareefy2026,
  author = {Al-Shareefy, Dhafar Mohamed Hasan},
  title = {Evaluating of Serum Potassium Levels in Patients with Kidney Disease},
  journal = {JOURNAL OF UNIVERSITY OF BABYLON for Pure and Applied Sciences},
  year = {2026},
  volume = {34},
  number = {3},
  pages = {505--518},
  doi = {10.29196/jubpas.v34i3.6845}
}
Kostenlos starten →